On Wednesday, FDA commissioner Scott Gottlieb announced his resignation, citing the toll the job takes on family life. The resignation could be a setback for the CBD industry, which is eagerly awaiting clarification from the FDA on how CBD will be regulated in the future.
In last week’s roundup, we noted that the World Health Organization’s Expert Committee on Drug Dependence had not yet presented their recommendations for the international scheduling of cannabis. The committee had been scheduled to release the report in December 2018. This week, the wait is finally over. The committee shared